EDSA vs MRNA · $64.2M cap vs rev $145.0M
Edesa Biotech Inc (EDSA) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Edesa Biotech Inc (EDSA) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
EDSA does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
EDSA currently screens at market cap $64.2M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the EDSA and MRNA stock pages for the full models.
Not investment advice.